Trinity Biotech PLC - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Trinity Biotech PLC. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Trinity Biotech PLC. The Group's principal activity is developing, manufacturing and marketing diagnostic test kits used for the clinical laboratory and point-of-care segments of the diagnostic market. These test kits are used to detect infectious diseases, sexually transmitted diseases, blood coagulation disorders and autoimmune disorders. The Group is also a provider of raw materials to the life sciences industry. Products brands are Amax, Biopool, CAPTIA, Macra, MicroTrak, Uni-Gold, Amelung, Bartels, Capillus, SeroCard, Recombigen and MarDx. The Group operates in Ireland, the United Kingdom, the United States of America, Germany and Sweden.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report